Maguy Daures1, Michele John2, Cécile Veysseyre Balter3, Olivier Simon4, Yann Barguil5, Isabelle Missotte6, Jean-Paul Grangeon2, Sylvie Laumond-Barny2, Martine Noel2, Laurent Besson-Leaud6, Pierre-Emmanuel Spasic7, Aurélie de Suremain6, Ann-Claire Gourinat8, Elodie Descloux7. 1. Public Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia. maguy.daures@gmail.com. 2. Public Health Service, New Caledonia Health Department, BP N4 - 98851, Nouméa, Cédex, New Caledonia. 3. Laboratory of Immunology, Team 2267, Claude Bernard University, Lyon, France. 4. Neurology Department, Noumea Territorial Hospital, Noumea, New Caledonia. 5. Biochemistry and Haemostasis Laboratory, Noumea Territorial Hospital, Noumea, New Caledonia. 6. Paediatrics Department, Noumea Territorial Hospital, Noumea, New Caledonia. 7. Department of Internal Medicine, Noumea Territorial Hospital, Noumea, New Caledonia. 8. Laboratory of Serology and Molecular Diagnosis, Pasteur Institute, Noumea, New Caledonia.
Abstract
PURPOSE: Invasive Meningococcal Disease (IMD) is three fold more common in New Caledonia (NC) than in metropolitan France and many IMD cases (35.7%) are due to Y and W135 serogroups. The purpose of our study was to identify IMD risk factors in NC. METHODS: A retrospective study of all IMD cases that occurred in NC between 2005 and 2011 was conducted. Socio-environmental, clinical and biological data were collected. A search for immune deficiency was proposed to all cases. IMD presentation and outcome were compared according to meningoccal serogroups and the complement deficiency status (C-deficiency). RESULTS: Sixty-six sporadic IMD cases (29 B serogroup, 20 Y or W135, 6 C, 1 A, 10 unknown) occurred in 64 patients often <24 years-old and of Melanesian origin. Five patients died (7.8%). No socio-environmental risk factors were identified. No asplenia, HIV infection or immunoglobulin deficiencies were found. Two patients had diabetes and 28 of 53 (52.8%) patients had C-deficiency including 20 (71.4%) cases of late complement component deficiency. Patients with C-deficiency were mainly Melanesian (92.8%) originating from the Loyalty Islands (62.1%). They were mostly infected with Y/W135 (42.9%) or B serogroups (32.1%). They often developed later and more severe disease than patients without C-deficiency (need for intensive cares in 60% versus 28.0% of cases, p = 0.01). CONCLUSIONS: A high prevalence of C-deficiency in the Melanesian population may explain epidemiological and clinical features of IMD in NC. Our results imply an adaptation of meningococcal vaccine strategies in NC.
PURPOSE: Invasive Meningococcal Disease (IMD) is three fold more common in New Caledonia (NC) than in metropolitan France and many IMD cases (35.7%) are due to Y and W135 serogroups. The purpose of our study was to identify IMD risk factors in NC. METHODS: A retrospective study of all IMD cases that occurred in NC between 2005 and 2011 was conducted. Socio-environmental, clinical and biological data were collected. A search for immune deficiency was proposed to all cases. IMD presentation and outcome were compared according to meningoccal serogroups and the complement deficiency status (C-deficiency). RESULTS: Sixty-six sporadic IMD cases (29 B serogroup, 20 Y or W135, 6 C, 1 A, 10 unknown) occurred in 64 patients often <24 years-old and of Melanesian origin. Five patients died (7.8%). No socio-environmental risk factors were identified. No asplenia, HIV infection or immunoglobulin deficiencies were found. Two patients had diabetes and 28 of 53 (52.8%) patients had C-deficiency including 20 (71.4%) cases of late complement component deficiency. Patients with C-deficiency were mainly Melanesian (92.8%) originating from the Loyalty Islands (62.1%). They were mostly infected with Y/W135 (42.9%) or B serogroups (32.1%). They often developed later and more severe disease than patients without C-deficiency (need for intensive cares in 60% versus 28.0% of cases, p = 0.01). CONCLUSIONS: A high prevalence of C-deficiency in the Melanesian population may explain epidemiological and clinical features of IMD in NC. Our results imply an adaptation of meningococcal vaccine strategies in NC.
Authors: A Audemard-Verger; E Descloux; D Ponard; A Deroux; B Fantin; C Fieschi; M John; A Bouldouyre; L Karkowsi; G Moulis; H Auvinet; F Valla; C Lechiche; B Davido; M Martinot; C Biron; F Lucht; N Asseray; A Froissart; R Buzelé; A Perlat; D Boutboul; V Fremeaux-Bacchi; S Isnard; B Bienvenu Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889